Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.58
BATS BZX Real-Time Price
As of 3:25pm ET
 +0.045 / +0.99%
Today’s Change
3.92
Today|||52-Week Range
8.38
-1.61%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close4.53
Today’s open4.55
Day’s range4.51 - 4.66
Volume41,509
Average volume (3 months)1,316,653
Market cap$593.5M
Data as of 3:25pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)+58.25%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.08+0.31%
TGTXTG Therapeutics Inc+0.35+2.49%
BYSIBeyondspring Inc0.000.00%
EGRXEagle Pharmaceutical...-0.05-0.09%
Data as of 3:26pm ET, 04/24/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts